BIOANALYTICAL SYSTEMS INC·4

May 21, 7:13 PM ET

Taylor Beth 4

4 · BIOANALYTICAL SYSTEMS INC · Filed May 21, 2020

Insider Transaction Report

Form 4
Period: 2020-05-19
Taylor Beth A.
Chief Financial Officer
Transactions
  • Purchase

    Common Shares

    2020-05-20$4.42/sh+4,933$21,80410,000 total
  • Purchase

    Common Shares

    2020-05-19$4.38/sh+5,067$22,1935,067 total
  • Purchase

    Common Shares

    2020-05-21$4.52/sh+3,300$14,91613,300 total
Footnotes (1)
  • [F1]The prices reported in column 4 are weighted average prices. These shares were purchased in multiple transactions at prices ranging from $4.26 to $4.39, inclusive with respect to the shares purchased on May 19, 2020, $4.22 to $4.81, inclusive with respect to the shares purchased on May 20, 2020, and $4.39 to $4.74, inclusive with respect to the shares purchased on May 21, 2020. The reporting person undertakes to provide to Bioanalytical Systems, Inc., any security holder of Bioanalytical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -